These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase. Fogel GB; Cheung M; Pittman E; Hecht D J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites. Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527 [TBL] [Abstract][Full Text] [Related]
9. Design and development of novel N-(4-aminobenzoyl)- l-glutamic acid conjugated 1,3,5-triazine derivatives as Pf-DHFR inhibitor: An in-silico and in-vitro study. Adhikari N; Choudhury AAK; Shakya A; Ghosh SK; Patgiri SJ; Singh UP; Bhat HR J Biochem Mol Toxicol; 2023 Apr; 37(4):e23290. PubMed ID: 36541419 [TBL] [Abstract][Full Text] [Related]
10. Expeditious synthesis and biological evaluation of novel 2,N6-disubstituted 1,2-dihydro-1,3,5-triazine-4,6-diamines as potential antimalarials. Gravestock D; Rousseau AL; Lourens AC; Moleele SS; van Zyl RL; Steenkamp PA Eur J Med Chem; 2011 Jun; 46(6):2022-30. PubMed ID: 21420762 [TBL] [Abstract][Full Text] [Related]
11. Shape- and chemical feature-based 3D-pharmacophore model generation and virtual screening: identification of potential leads for P. falciparum DHFR enzyme inhibition. Adane L; Patel DS; Bharatam PV Chem Biol Drug Des; 2010 Jan; 75(1):115-26. PubMed ID: 19895504 [TBL] [Abstract][Full Text] [Related]
12. Quantitative structure activity relationship study of 2,4,6-trisubstituted-s-triazine derivatives as antimalarial inhibitors of Plasmodium falciparum dihydrofolate reductase. Ojha H; Gahlot P; Tiwari AK; Pathak M; Kakkar R Chem Biol Drug Des; 2011 Jan; 77(1):57-62. PubMed ID: 20958921 [TBL] [Abstract][Full Text] [Related]
13. Plasmodium falciparum: kinetic interactions of WR99210 with pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase. Hekmat-Nejad M; Rathod PK Exp Parasitol; 1997 Nov; 87(3):222-8. PubMed ID: 9371087 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of 6-aryl-1,6-dihydro-1,3,5-triazine-2,4-diamines as antiplasmodial antifolates. Lourens AC; Gravestock D; van Zyl RL; Hoppe HC; Kolesnikova N; Taweechai S; Yuthavong Y; Kamchonwongpaisan S; Rousseau AL Org Biomol Chem; 2016 Aug; 14(33):7899-911. PubMed ID: 27477595 [TBL] [Abstract][Full Text] [Related]
15. In vitro antimalarial activity and molecular docking analysis of 4-aminoquinoline-clubbed 1,3,5-triazine derivatives. Bhat HR; Ghosh SK; Prakash A; Gogoi K; Singh UP Lett Appl Microbiol; 2012 May; 54(5):483-6. PubMed ID: 22394198 [TBL] [Abstract][Full Text] [Related]
16. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy. Mukherjee P; Pradhan A; Shah F; Tekwani BL; Avery MA Bioorg Med Chem; 2008 May; 16(9):5254-65. PubMed ID: 18362073 [TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationships for cycloguanil analogs as PfDHFR inhibitors using mathematical molecular descriptors. Basak SC; Mills D SAR QSAR Environ Res; 2010 Apr; 21(3-4):215-29. PubMed ID: 20544548 [TBL] [Abstract][Full Text] [Related]
20. Translational up-regulation of antifolate drug targets in the human malaria parasite Plasmodium falciparum upon challenge with inhibitors. Nirmalan N; Sims PF; Hyde JE Mol Biochem Parasitol; 2004 Jul; 136(1):63-70. PubMed ID: 15138068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]